Tune In With Spark

Interview with the executive director of Recce Pharmaceuticals, James Graham. Recce Pharmaceutical is listed on the ASX with the ticker RCE.

Interview Timestamps:

(02:00) Introduction to Recce Pharmaceuticals

(03:40) Clinical Trials with Parexel

(06:20) COVID-19's impact on the business

(09:50) R&D rebates in Australia

(11:10) Investors engagement

(12:45) Introduction to the team

(14:20) Definition of success for Recce Pharmaceuticals

Disclaimer:

Do note that our content is intended to be used and must be used for informational purposes only. Under no circumstances does the information presented in this podcast represent a buy, sell or hold recommendation on any security. This podcast does not constitute accounting, legal, tax, or other professional advice. Listeners should not act upon the content or information found here without first seeking appropriate advice from an accountant, financial planner, lawyer or other professional.

We give no assurance or warranty regarding the accuracy, timeliness, or applicability of any of the contents. We assume no responsibility for information contained on this website and disclaim all liability in respect of such information, including but not limited to any liability for errors, inaccuracies, omissions, or misleading or defamatory statements.

Listening to this podcast constitutes an explicit understanding and acceptance of the terms of this disclaimer.

#ASX #Interviews #CEO #Investing #Business

Interview with Founder and CEO of Aptorum Group, Ian Huen. Aptorum is listed on the NASDAQ with the ticker APM.

Interview Timestamps:

(01:15) Current Situation of Aptorum.

(02:35) Introduction to Aptorum.

(05:35) Partnership with Covar Pharmaceutical.

(07:35) Process to get into clinical trials.

(08:35) Support of the Hong Kong government on clinical research.

(09:35) Management team of Aptorum

(11:50) Challenges of investor education for an early-stage company in the biotechnology/pharmaceutical sector.

(15:40) Evolution of Aptorum.

(17:55) Methods for investor outreach.

Disclaimer:

Do note that our content is intended to be used and must be used for informational purposes only. Under no circumstances does the information presented in this podcast represent a buy, sell or hold recommendation on any security. This podcast does not constitute accounting, legal, tax, or other professional advice. Listeners should not act upon the content or information found here without first seeking appropriate advice from an accountant, financial planner, lawyer or other professional.

We give no assurance or warranty regarding the accuracy, timeliness, or applicability of any of the contents. We assume no responsibility for information contained on this website and disclaim all liability in respect of such information, including but not limited to any liability for errors, inaccuracies, omissions, or misleading or defamatory statements.

Listening to this podcast constitutes an explicit understanding and acceptance of the terms of this disclaimer.

#ASX #Interviews #CEO #Investing #Business

Tune in with Spark is a weekly podcast where we interview CEOs of listed companies to find out more about their journey and thoughts on the current economy.

Interview with managing director of Brookside Energy, David Prentice. Brookside Energy is listed on the ASX with the ticker BRK. 

Timestamps:

1. (01:13) Start of Interview
2. (01:24) Introduction to Brookside Energy
3. (02:53) Why did Brookside focus on the Anadarko Basin?
4. (04:46) How did the recent oil prices changes affected Brookside?
5. (06:52) How has COVID affect the operations?
6. (09:00) How do you engage investors during such a period?
7. (10:00) How does Brookside look for areas?
8. (15:23) Background of management team
9. (18:00) What motivates the MD?

Disclaimer:

Do note that our content is intended to be used and must be used for informational purposes only. Under no circumstances does the information presented in this podcast represent a buy, sell or hold recommendation on any security. This podcast does not constitute accounting, legal, tax, or other professional advice. Listeners should not act upon the content or information found here without first seeking appropriate advice from an accountant, financial planner, lawyer or other professional. 

We give no assurance or warranty regarding the accuracy, timeliness, or applicability of any of the contents. We assume no responsibility for information contained on this website and disclaim all liability in respect of such information, including but not limited to any liability for errors, inaccuracies, omissions, or misleading or defamatory statements.

Listening to this podcast constitutes an explicit understanding and acceptance of the terms of this disclaimer.